Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study

BackgroundObesity affects >890 million adults worldwide, and traditional lifestyle interventions often lack long-term success. While glucagonlike peptide-1 receptor agonists (GLP-1RAs) have shown strong weight loss outcomes, access to specialist care is limited by cost and...

Full description

Bibliographic Details
Published in:JMIR Formative Research
Main Authors: Rebecca Richards, William Lunt, Michael Whitman, Giulia Spaltro, Rachel Hall
Format: Article
Language:English
Published: JMIR Publications 2025-09-01
Online Access:https://formative.jmir.org/2025/1/e81912